{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T15:04:51Z","timestamp":1773155091747,"version":"3.50.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T00:00:00Z","timestamp":1735862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T00:00:00Z","timestamp":1735862400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Health Inf Sci Syst"],"DOI":"10.1007\/s13755-024-00323-5","type":"journal-article","created":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T23:20:26Z","timestamp":1735860026000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Causal relationship between apolipoprotein B and risk of atherosclerotic cardiovascular disease: a mendelian randomization analysis"],"prefix":"10.1007","volume":"13","author":[{"given":"Xiangyong","family":"Kong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanchen","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8719-3999","authenticated-orcid":false,"given":"Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,3]]},"reference":[{"issue":"6","key":"323_CR1","first-page":"521","volume":"36","author":"China Cardiovascular Health and Disease Report Writing Group","year":"2021","unstructured":"China Cardiovascular Health and Disease Report Writing Group. Summary of the China cardiovascular health and disease report 2020. Chin J Circul. 2021;36(6):521\u201345.","journal-title":"Chin J Circul"},{"issue":"25","key":"323_CR2","first-page":"e1082","volume":"139","author":"SM Grundy","year":"2019","unstructured":"Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, Braun LT, de Ferranti S, Faiella-Tommasino J, Forman DE, Goldberg R, Heidenreich PA, Hlatky MA, Jones DW, Lloyd-Jones D, Lopez-Pajares N, Ndumele CE, Orringer CE, Peralta CA, Saseen JJ, Smith SC Jr, Sperling L, Virani SS, Yeboah J. 2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American college of cardiology\/american heart association task force on clinical practice guidelines. Circulation. 2019;139(25):e1082\u2013143.","journal-title":"Circulation"},{"issue":"1","key":"323_CR3","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","volume":"41","author":"F Mach","year":"2020","unstructured":"Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, Chapman MJ, De Backer GG, Delgado V, Ference BA, Graham IM, Halliday A, Landmesser U, Mihaylova B, Pedersen TR, Riccardi G, Richter DJ, Sabatine MS, Taskinen MR, Tokgozoglu L, Wiklund O. ESC scientific document group. 2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41(1):111\u201388.","journal-title":"Eur Heart J"},{"issue":"10","key":"323_CR4","first-page":"937","volume":"31","author":"Joint Committee on Revision of Chinese Guidelines for Prevention and Control of Dyslipidaemia in Adults","year":"2016","unstructured":"Joint Committee on Revision of Chinese Guidelines for Prevention and Control of Dyslipidaemia in Adults. Guidelines for prevention and control of dyslipidaemia in Chinese adults (2016 revised edition). Chin J Circul. 2016;31(10):937\u201350.","journal-title":"Chin J Circul"},{"issue":"6","key":"323_CR5","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s11886-019-1128-6","volume":"21","author":"D Sinning","year":"2019","unstructured":"Sinning D, Landmesser U. Is there a need to revise goals in the management of dyslipidemias? Curr Cardiol Rep. 2019;21(6):51.","journal-title":"Curr Cardiol Rep"},{"issue":"10","key":"323_CR6","doi-asserted-by":"publisher","first-page":"690","DOI":"10.3390\/metabo11100690","volume":"11","author":"J Behbodikhah","year":"2021","unstructured":"Behbodikhah J, Ahmed S, Elyasi A, Kasselman LJ, De Leon J, Glass AD, Reiss AB. Apolipoprotein B and cardiovascular disease: biomarker and potential therapeutic target. Metabolites. 2021;11(10):690.","journal-title":"Metabolites"},{"issue":"6","key":"323_CR7","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.jacc.2016.11.042","volume":"69","author":"S Tsimikas","year":"2017","unstructured":"Tsimikas S. A test in context: lipoprotein(a): diagnosis, prognosis, controversies, and emerging therapies. J Am Coll Cardiol. 2017;69(6):692\u2013711.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"323_CR8","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/MOL.0000000000000330","volume":"27","author":"J Bor\u00e9n","year":"2016","unstructured":"Bor\u00e9n J, Williams KJ. The central role of arterial retention of cholesterol-rich apolipoprotein-B-containing lipoproteins in the pathogenesis of atherosclerosis: a triumph of simplicity. Curr Opin Lipidol. 2016;27(5):473\u201383.","journal-title":"Curr Opin Lipidol"},{"issue":"12","key":"323_CR9","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1001\/jamacardio.2019.3780","volume":"4","author":"AD Sniderman","year":"2019","unstructured":"Sniderman AD, Thanassoulis G, Glavinovic T, Navar AM, Pencina M, Catapano A, Ference BA. Apolipoprotein B particles and cardiovascular disease: a narrative review. JAMA Cardiol. 2019;4(12):1287\u201395.","journal-title":"JAMA Cardiol"},{"issue":"3","key":"323_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003062","volume":"17","author":"TG Richardson","year":"2020","unstructured":"Richardson TG, Sanderson E, Palmer TM, Ala-Korpela M, Ference BA, Davey Smith G, Holmes MV. Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: a multivariable Mendelian randomisation analysis. PLoS Med. 2020;17(3): e1003062.","journal-title":"PLoS Med"},{"issue":"3","key":"323_CR11","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1093\/ije\/dyaa216","volume":"50","author":"V Zuber","year":"2021","unstructured":"Zuber V, Gill D, Ala-Korpela M, Langenberg C, Butterworth A, Bottolo L, Burgess S. High-throughput multivariable Mendelian randomization analysis prioritizes apolipoprotein B as key lipid risk factor for coronary artery disease. Int J Epidemiol. 2021;50(3):893\u2013901.","journal-title":"Int J Epidemiol"},{"issue":"22","key":"323_CR12","doi-asserted-by":"publisher","first-page":"3375","DOI":"10.1161\/CIRCULATIONAHA.104.532499","volume":"112","author":"T Pischon","year":"2005","unstructured":"Pischon T, Girman CJ, Sacks FM, Rifai N, Stampfer MJ, Rimm EB. Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men. Circulation. 2005;112(22):3375\u201383.","journal-title":"Circulation"},{"issue":"2","key":"323_CR13","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1093\/rheumatology\/keaa506","volume":"60","author":"YL Dan","year":"2021","unstructured":"Dan YL, Wang P, Cheng Z, Wu Q, Wang XR, Wang DG, Pan HF. Circulating adiponectin levels and systemic lupus erythematosus: a two-sample Mendelian randomization study. Rheumatology. 2021;60(2):940\u20136.","journal-title":"Rheumatology"},{"key":"323_CR14","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.atherosclerosis.2019.08.014","volume":"290","author":"F Mach","year":"2019","unstructured":"Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L. Authors\/task force members; esc committee for practice guidelines (CPG); ESC national cardiac societies. 2019 ESC\/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. Atherosclerosis. 2019;290:140\u2013205.","journal-title":"Atherosclerosis"},{"issue":"12","key":"323_CR15","first-page":"1000","volume":"48","author":"Chinese Society of Cardiovascular Disease","year":"2020","unstructured":"Chinese Society of Cardiovascular Disease, Chinese Society of Rehabilitation Medicine, Chinese Society of Gerontology and Geriatrics, Chinese Society of Gerontology and Geriatrics, Cardiology Committee. Guidelines for primary prevention of cardiovascular disease in China. Chin J Cardiovasc Dis. 2020;48(12):1000\u201338.","journal-title":"Chin J Cardiovasc Dis"},{"issue":"1","key":"323_CR16","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1007\/s12035-016-0346-9","volume":"55","author":"XW Hong","year":"2018","unstructured":"Hong XW, Wu DM, Lu J, Zheng YL, Tu WJ, Yan J. Lipoprotein (a) as a predictor of early stroke recurrence in acute ischemic stroke. Mol Neurobiol. 2018;55(1):718\u201326.","journal-title":"Mol Neurobiol"}],"container-title":["Health Information Science and Systems"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13755-024-00323-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13755-024-00323-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13755-024-00323-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T09:08:31Z","timestamp":1765444111000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13755-024-00323-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,3]]},"references-count":16,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["323"],"URL":"https:\/\/doi.org\/10.1007\/s13755-024-00323-5","relation":{},"ISSN":["2047-2501"],"issn-type":[{"value":"2047-2501","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,3]]},"assertion":[{"value":"3 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We, the authors, hereby declare that there are no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. We have no relevant financial or other interests to disclose in relation to the work described.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"13"}}